17-Jan-2012 - Bayer MaterialScience AG

Bayer MaterialScience commissions new hydrogenation technical center

Pooling of research activities for the efficient production of MDI and TDI

Bayer MaterialScience has commissioned a new technical center for the development of isocyanate production processes at Chempark Dormagen. The research center was erected in just under a year with an investment of EUR 5 million.

“All global research activities related to the production of aromatic isocyanates have now been pooled in the new hydrogenation technical center,” said Dr. Joachim Wolff, head of the polyurethanes business and member of the Executive Committee of Bayer MaterialScience, on the occasion of the commissioning. “The associated efficiency gains in the research and optimization of the production processes will help to further expand our global technological leadership.”

The state-of-the-art facility is focused on hydrogenation technology for the production of precursors to diphenylmethane diisocyanate (MDI) and toluene diisocyanate (TDI). MDI is the starting product for rigid polyurethane foam, which enables particularly efficient insulation of buildings, in particular. Over its service life, it saves as much as 70 times more energy than is needed to produce the foam. TDI is used to make flexible polyurethane foam for comfortable upholstered furniture and mattresses.

MDI is based on benzene, which is first nitrated into nitrobenzene and then hydrogenated to produce aniline. An additional step then converts the aniline to diphenylmethane diamine, the direct precursor to MDI. A catalyst is used to produce aniline from nitrobenzene and hydrogen gas. With the conventional isothermic process, which is performed at a constant temperature, the substantial heat generated during the reaction must be dissipated using heat transfer oils. The reaction takes place inside a reactor block, in which many thousands of tubes containing the catalyst have been welded together. Finally, the aniline must be painstakingly purified of byproducts before it can be used further.

The adiabatic variant developed by Bayer MaterialScience is a current example of innovative process development in the area of hydrogenation. The technology eliminates the need for heat transfer and enables a substantial gain in efficiency. Here the reaction takes place in a large steel vessel, in which the catalyst is placed on a grating. The heat of reaction is dissipated together with the gas flow, eliminating the need for the circulating oil loop. In addition, the product is also of significantly higher purity. “The technology is already proving to be extremely successful in our world-scale facility in Shanghai, China, with an annual production capacity of 350,000 metric tons. The conventional process would have been too complex and too expensive for a facility of this size,” said Dr. Thorsten Dreier, who heads the isocyanate research department at polyurethane production.

The researchers plan to concentrate on the further optimization of both process variants at the new technical center. Other focal points will be researching and improving the hydrogenation of dinitrotoluene to obtain toluene diamine, the direct precursor to TDI, and also the Deacon process for the oxidation of hydrogen chloride.

Facts, background information, dossiers
More about Bayer MaterialScience
  • News

    Covestro up and running

    Bayer MaterialScience is from now on operating under the Covestro name. The company is now legally and economically independent, but will remain a 100 percent subsidiary of Bayer AG. Bayer wants to float Covestro on the stock market by mid-2016 at the latest in order to concentrate exclusiv ... more

    Covestro Management Board named

    The Supervisory Board of Bayer MaterialScience AG (in future: Covestro) has named the members of the future Covestro Board of Management effective September 1, 2015. Patrick Thomas (57) has been confirmed as Chairman of the Board of Management of Covestro. He has been CEO of Bayer MaterialS ... more

    Bayer MaterialScience: Further milestone in the manufacture of plastics from CO2

    Bayer MaterialScience has taken another major step toward using CO2 for plastic production from 2016. A production line is currently under construction for this purpose at the Dormagen site in Germany. A chemical reactor weighing some 25 metric tons has now been put in place at the heart of ... more

  • Companies

    Bayer MaterialScience LLC

    Bayer MaterialScience LLC is one of the leading producers of polymers and high-performance plastics in North America and is part of the global Bayer MaterialScience business with nearly 19,000 employees at 40 sites around the world and 2005 sales of 10.7 billion euros. Our innovative develo ... more

More about Bayer
  • News

    Bayer strategically and operationally successful

    Bayer was strategically and operationally successful last year. “We delivered in 2019 and kept our promises in all areas,” Werner Baumann, Chairman of the Board of Management, said on Thursday at the Financial News Conference in Leverkusen. “We achieved our financial targets despite coming ... more

    Norbert Winkeljohann to succeed Werner Wenning as Chairman of Bayer’s Supervisory Board

    Prof. Dr. Norbert Winkeljohann, 62, is to become Chairman of the Supervisory Board of Bayer AG. As decided at Supervisory Board meeting, Winkeljohann will succeed Werner Wenning, 73, who is to step down with effect from the end of the Annual Stockholders’ Meeting on April 28, 2020. Winkeljo ... more

    Bayer completes sale of Currenta stake

    Bayer has completed the sale of its 60 percent stake in chemical park operator Currenta to funds managed by Macquarie Infrastructure and Real Assets (MIRA). The two companies had entered into an agreement to this effect back in August. The closing conditions, including approval by the respo ... more

  • Companies

    Bayer Technology Services México

    Bayer Technology Services stands for technological competence throughout the service life of processes or units. We support our customers from the development of innovative products and processes to engineering and construction of units, to operating control and optimization – with courage, ... more

    Bayer Corporation

    Bayer Corporation, headquartered in Pittsburgh, is a subsidiary of Bayer AG, an international health care, nutrition and innovative materials group based in Leverkusen, Germany. In North America, Bayer had 2006 net sales of 7.8 billion euros and employed 17,200 at year end. Bayer’s three s ... more

    Bayer S.A./NV.

    Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and high earni ... more